Driehaus Capital Management LLC

Position in NEO — Neogenomics Inc

CIK 938206 Chicago, IL

Position in NEO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$12,775,385

-$16,292,253 QoQ

Shares Held

1,721,750

-30.3% QoQ

Ownership

1.32%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 83.40955423261217.ToString("F0")% Shared 0.ToString("F0")% None 16.59044576738783.ToString("F0")%

Healthcare · as of Mar 31, 2026

Driehaus Capital Management LLC holds $263,026,067 across 6 Diagnostics & Research names. NEO ranks #5 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GH	Guardant Health, Inc.	1,524,282	$140,797,928
2	NTRA	Natera, Inc.	284,338	$56,864,756
3	TWST	Twist Bioscience Corp	584,696	$27,784,753
4	ADPT	Adaptive Biotechnologies Corp	1,750,601	$24,298,341
5	NEO	Neogenomics Inc This page	1,721,750	$12,775,385
6	DHR	Danaher Corp /De/	2,663	$504,904

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,775,385	1,721,750	-30.3%	Shares	Sole	2026-05-15
2025-12-31	$29,067,638	2,471,738	+537.6%	Shares	Sole	2026-02-17
2024-09-30	$5,717,734	387,643	-50.4%	Shares	Sole	2024-11-14
2023-12-31	$12,648,472	781,735	+76.4%	Shares	Sole	2024-02-14
2023-09-30	$5,450,535	443,133	-0.2%	Shares	Sole	2023-11-14
2023-06-30	$7,136,542	444,091	+1232.3%	Shares	Sole	2023-08-14
2021-12-31	$1,137,321	33,333	-96.0%	Shares	Sole	2022-02-14
2021-09-30	$40,117,782	831,629	+47.5%	Shares	Sole	2021-11-15
2021-06-30	$25,462,148	563,696	-14.9%	Shares	Sole	2021-08-16
2021-03-31	$31,937,616	662,194	+23.4%	Shares	Sole	2021-05-17
2020-12-31	$28,898,189	536,742	-7.9%	Shares	Sole	2021-02-16
2020-09-30	$21,508,972	583,057	-0.7%	Shares	Sole	2020-11-16
2020-06-30	$18,194,337	587,293	-26.4%	Shares	Sole	2020-08-14
2020-03-31	$22,022,923	797,643	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.